Edition:
United States

Alexion Pharmaceuticals Inc (ALXN.OQ)

ALXN.OQ on NASDAQ Stock Exchange Global Select Market

115.76USD
15 Dec 2017
Change (% chg)

$2.67 (+2.36%)
Prev Close
$113.09
Open
$114.07
Day's High
$116.54
Day's Low
$112.62
Volume
1,593,098
Avg. Vol
640,169
52-wk High
$149.17
52-wk Low
$96.18

Get access to over 18 million research reports from over 1,700 sources.

For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.

Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.

Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:

  • ownership
  • filings
  • deals
  • private equity
  • third-party document and information retrieval
  • estimates
  • fundamentals
  • economics
  • events
  • news
  • and much, much more…

Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.

Name Age Since Current Position

David Brennan

63 2017 Chairman of the Board

Ludwig Hantson

54 2017 Chief Executive Officer, Director

Paul Clancy

55 2017 Chief Financial Officer

John Moriarty

49 2014 Executive Vice President, General Counsel

Martin Mackay

60 2013 Executive Vice President, Global Head - Research and Development